Comparison between adrenaline vs noradrenaline in children with cancer presenting with shock
- Conditions
- Health Condition 1: R031- Nonspecific low blood-pressure reading
- Registration Number
- CTRI/2022/09/045180
- Lead Sponsor
- Apollo Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Hematoncology patients aged 1 month to 17 years with early shock, defined as children with unresolved shock/hypoperfusion after the initial 10- 20ml/kg fluid bolus.
1.Children with fulminant myocarditis
2.Children with established, untreated heart disease
3.Parents not willing to participate in the study
4.Caregiver/Physician unwilling for patient to be enrolled
5.Post-arrest shock
6.Moribund patients in whom anticipated survival < 24 hrs (since many are in recalcitrant downward spiral of overall condition where the impact of one or other vasoactive may be difficult to assess).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.